Review
Sep 2026
SGLT2 Inhibitors in Cardiovascular-Kidney-Metabolic Syndrome: Drugs Unifying Heart, Kidney, and Metabolism Pharmacotherapy.
Valentina Okhovat, Kamela Lybeshari, Luigi X. Cubeddu et al.
· American Journal of Cardiova... · 0 citations